Navigation Links
Avastin Approved in Europe for First-Line Treatment of Patients With Advanced Kidney Cancer
Date:12/19/2007

, breast, lung, and now kidney cancer:
-- February 2004 (US) and January 2005 (EU) - first-line treatment in

patients with metastatic colorectal cancer (CRC)

-- June 2006 (US) - second-line treatment in patients with metastatic CRC

-- October 2006 (US) - first-line treatment in patients with advanced non

small cell lung cancer (NSCLC)

-- March 2007 (EU) - first-line treatment in patients with metastatic

breast cancer

-- April 2007 (Japan) - treatment in patients with recurrent or advanced

CRC

-- August 2007 (EU) - first-line treatment in patients with advanced NSCLC

-- December 2007 (EU) - first-line treatment in patients with advanced RCC

About the AVOREN Study

The AVOREN study is a randomised, controlled, double-blind, phase III study that included 649 patients with advanced kidney cancer from 101 study sites across 18 countries. Study participants received treatment with either Avastin and IFN alpha-2a or placebo and IFN alpha-2a, the standard of care in patients with advanced kidney cancer.
The results of the AVOREN trial showed that by adding Avastin to IFN:

-- Progression free survival (PFS) was almost doubled from a median of 5.4

to 10.2 months

-- Tumour response was significantly increased from 12.8% with IFN alone

to 31.4% when Avastin was added

-- Dose-reduction of IFN did not appear to affect the efficacy of the

combination with Avastin (based on PFS event free rates over time, as

shown by a sub-group analysis)

The study also showed a trend towards improved overall survival; however, these data are still pending. No new or unexpected adverse events were observed.

An interim analysis of AVOREN was performed in December 2006 and the benefits provided by Avastin were so positive that the Drug Safety Monitoring Board recommended that the trial was unblinded and all patients were offered t
'/>"/>

SOURCE Roche
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Shires ELAPRASE(R) (idursulfase) Approved in Japan for the Treatment of Hunter Syndrome
2. Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM)
3. Healthcare Announced That an Overwhelming Majority of its Shareholders Approved the NexGen Biofuels Transaction
4. Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension
5. European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreichs Ataxia by Santhera
6. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
7. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
8. Medpace Strengthens Presence in Central Europe
9. Kline Study: Better Brushing Habits Boost European Oral Care Sales
10. Micromet, Inc. to Present at the Sal. Oppenheim 2nd European Healthcare Conference
11. European Centre for Modern Drug Discovery Established in Hamburg
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Diego, Calif. (PRWEB) June 02, 2015 ... of build-to-order, independent blade-based and rackmount computing and ... today announced the launch of its high density ... the Cirrascale Slipstream™ RM1622D . The high ... processor E3-1200 v4 product family with Intel® Iris™ ...
(Date:6/2/2015)... --  BioClinica ® , Inc., a specialty clinical ... David Peters , an accomplished senior finance and accounting ... Financial Officer (CFO) and will be joining BioClinica on ... 25 years of financial and accounting experience with a ... knowledge in all areas of finance, accounting and business ...
(Date:6/2/2015)... , June 2, 2015 /PRNewswire/ -- China Cord Blood Corporation ... "our"), China,s leading provider of cord ... cell storage services, today announced that the Special Committee of ... Houlihan Lokey ( China ) Limited ... & Hamilton LLP as its United States ...
(Date:6/2/2015)... 2015 MGB Biopharma at ... problem  MGB Biopharma, a biopharmaceutical company ... address the major global problem of antibiotic resistance ... intravenous (IV) formulation of MGB-BP-3, designed for the treatment ... The intravenous formulation of MGB-BP-3 is currently ...
Breaking Biology Technology:Cirrascale® Announces Support for Intel® Xeon® Processor E3-1200 v4 Product Family; Launches Server Offering Optimized for Low Cost-per-Stream Transcoding Applications 2Cirrascale® Announces Support for Intel® Xeon® Processor E3-1200 v4 Product Family; Launches Server Offering Optimized for Low Cost-per-Stream Transcoding Applications 3BioClinica Names David Peters New Chief Financial Officer 2China Cord Blood Corporation's Special Committee Appoints Independent Financial Advisor and Legal Counsel to Evaluate Non-binding "Going Private" Proposal 2China Cord Blood Corporation's Special Committee Appoints Independent Financial Advisor and Legal Counsel to Evaluate Non-binding "Going Private" Proposal 3MGB Biopharma Succeeds in Developing an IV Formulation of MGB-BP-3 for the Treatment of Systemic Susceptible and Resistant Gram-Positive Hospital-Acquired Infections 2MGB Biopharma Succeeds in Developing an IV Formulation of MGB-BP-3 for the Treatment of Systemic Susceptible and Resistant Gram-Positive Hospital-Acquired Infections 3
... 28 Entest BioMedical, Inc., a newly formed wholly-owned ... Bulletin Board: BMSN) announced today the launch of its ... to focus on new stem cell research, including a ... traumatic brain injury (TBI) using autologous adipose-derived (fat) stem ...
... ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF ), ... solutions, announced today that VWR International, LLC (VWR) has ... Chester, Pennsylvania, VWR is a global laboratory supply and ... billion. , "The U.S. is an important market for ...
... Diagnostics scientists will present results of three studies revealing ... treatment of chronic myeloid leukemia (CML) and prostate cancer ... of Clinical Oncology (ASCO), scheduled for May 29 through ... DGX ) is the world,s leading provider ...
Cached Biology Technology:New Stem Cell Web Site to Focus on Traumatic Brain Injury, Spinal Cord Injury and Diabetes 2MedMira Strengthens North American Sales Channels, Adding VWR as Distributor for the United States 2Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting 2Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting 3Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting 4Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting 5
(Date:5/21/2015)... 2015 According to a ... (Hardware, Software, Services), by Applications (Surveillance (Airborne, Maritime, ... End-Users (Military & Defense & Commercial) - Global ... Market is expected to grow from $7252.0 Million ... a Compound Annual Growth Rate (CAGR) of 6.6%. ...
(Date:5/19/2015)... Sweden , May 18, 2015 ... fingerprint sensors FPC1020, FPC1025, FPC1145, FPC1155 and FPC1035 from one ... from June until and including Q3 2015 and the sensors ... . Communicated order values for 2015 hereby amount to ... for Q1 2015 of 140 MSEK and a number of ...
(Date:5/14/2015)... , May 14, 2015 Research and Markets ... the "Fingerprint Sensors Market in Smart Mobile Devices ... report believes that 2014 was a watershed year for ... introduction of ,Apple Pay,. Apple gave fingerprint sensors a ... payment service. Fingerprint sensors are a must-have feature in ...
Breaking Biology News(10 mins):Thermal Imaging Market Worth $9,998.9 Million by 2020 2Thermal Imaging Market Worth $9,998.9 Million by 2020 3Thermal Imaging Market Worth $9,998.9 Million by 2020 4Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2
... this release has been changed to 7 p.m. EST Sept. ... that the global distribution of macro- and microorganisms might be ... Evolutionary Biology, shows that some protozoa are globally dispersed, while ... fast-evolving DNA marker. The study also reveals that the biodiversity ...
... islet cells from pigs may be used in clinical ... diabetes. This key finding was the discovery ... Institute for Immunology & Transplantation at the University of ... in the prestigious scientific journal Nature Medicine in March ...
... at Childrens Hospital of Pittsburgh of UPMC have ... a vaccine against Chlamydia trachomatis, the most prevalent ... The researchers, led by Toni Darville, MD, chief ... Childrens, identified a plasmid-deficient strain of Chlamydia that, ...
Cached Biology News:DNA analysis shows true dispersal of protozoa 2Breakthrough research identifies how cells from pigs may cure diabetes 2Study by Pittsburgh researchers identifies possible vaccine target for chlamydia 2
... cm, is used for vertical slab gel electrophoresis ... The cell is supplied without spacers and combs. ... gaskets, lower buffer chamber, lid with cables, 2 ... buffer dam, casting stand with gaskets, leveling bubble, ...
... PROTEAN II xi cell, 20 cm, is used ... and proteins in agarose gels. The cell is ... a central cooling core with gaskets, lower buffer ... plates, 4 sandwich clamps, upper buffer dam, casting ...
CleanCut agarose is used to prepare genomic DNA plugs for use in pulsed field gel electrophoresis (PFGE) applications. Supplied as a 12 ml solution of 2% agarose....
... minor groove-binding probe for DNA. Binds to ... to AT rich DNA), forming a stable ... than DAPI alone. DAPI is several times ... DNA in agarose gels. It may be ...
Biology Products: